Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitis

BACKGROUND: Baseline expression of FCRL5, a marker of naive and memory B cells, was shown to predict response to rituximab (RTX) in rheumatoid arthritis. This study investigated baseline expression of FCRL5 as a potential biomarker of clinical response to RTX in granulomatosis with polyangiitis (GPA...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JCI Insight
Egile Nagusiak: Owczarczyk, Kasia, Cascino, Matthew D., Holweg, Cecile, Tew, Gaik W., Ortmann, Ward, Behrens, Timothy, Schindler, Thomas, Langford, Carol A., St. Clair, E. William, Merkel, Peter A., Spiera, Robert, Seo, Philip, Kallenberg, Cees G.M., Specks, Ulrich, Lim, Noha, Stone, John, Brunetta, Paul, Prunotto, Marco
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Clinical Investigation 2020
Gaiak:
Clinical Medicine
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7526555/
https://ncbi.nlm.nih.gov/pubmed/32841219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.136180
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak